Published in J Virol on August 01, 1980
Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol (1984) 6.67
Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol (1982) 6.20
Organization and expression of the immediate early genes of human cytomegalovirus. J Virol (1983) 5.74
Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J Virol (1985) 5.09
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection. J Virol (1981) 4.11
Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol (1989) 3.98
Autoregulation of the human cytomegalovirus major immediate-early gene. J Virol (1985) 2.91
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
Identification and characterization of human cytomegalovirus-encoded microRNAs. J Virol (2005) 2.73
A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection. J Virol (1989) 2.70
Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. J Virol (1989) 2.68
Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol (1991) 2.61
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol (1989) 2.32
Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter. J Virol (1990) 2.28
Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol (2007) 1.90
Characterization of a viable, noninverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S. Proc Natl Acad Sci U S A (1983) 1.85
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Human cytomegalovirus UL36-38 and US3 immediate-early genes: temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J Virol (1991) 1.81
Expression of a human cytomegalovirus late gene is posttranscriptionally regulated by a 3'-end-processing event occurring exclusively late after infection. Mol Cell Biol (1986) 1.78
Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J Virol (1993) 1.73
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol (1993) 1.68
A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J Virol (1991) 1.62
Protein-protein interactions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J Virol (1994) 1.62
Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol (1995) 1.52
Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J Virol (1993) 1.51
CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. J Virol (1995) 1.47
Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products. J Virol (1994) 1.43
Analysis and mapping of a family of 3'-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J Virol (1995) 1.37
An inducible promoter mediates abundant expression from the immediate-early 2 gene region of human cytomegalovirus at late times after infection. J Virol (1991) 1.33
Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation. J Virol (1992) 1.31
The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF. J Virol (2000) 1.28
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination. J Virol (1996) 1.13
Whole-genome analysis of pseudorabies virus gene expression by real-time quantitative RT-PCR assay. BMC Genomics (2009) 1.07
Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region. J Virol (1995) 1.05
Analysis of a region of the human cytomegalovirus (AD169) genome coding for a 25-kilodalton virion protein. J Virol (1989) 1.04
The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein. J Virol (1995) 1.02
Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter. J Virol (1995) 1.00
Characterization of a human cytomegalovirus 1.6-kilobase late mRNA and identification of its putative protein product. J Virol (1991) 1.00
The human cytomegalovirus 86-kilodalton immediate-early 2 protein: synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin. J Virol (1994) 0.99
Binding of SP1 to the immediate-early protein-responsive element of the human cytomegalovirus DNA polymerase promoter. J Virol (1997) 0.98
Characterization of the major locus of immediate-early genes of rat cytomegalovirus. J Virol (1993) 0.95
Novel immediate-early protein IE19 of human cytomegalovirus activates the origin recognition complex I promoter in a cooperative manner with IE72. J Virol (2002) 0.94
The DNA damage response induced by infection with human cytomegalovirus and other viruses. Viruses (2014) 0.90
Transcriptional analysis of the eight-kilobase mRNA encoding the major capsid protein of human cytomegalovirus. J Virol (1990) 0.89
Potential of in situ hybridization for early diagnosis of productive cytomegalovirus infection. J Clin Microbiol (1988) 0.83
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82
Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression. J Virol (2001) 0.82
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun (1966) 71.25
Amino acid metabolism in mammalian cell cultures. Science (1959) 55.21
Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome. Cell (1977) 7.60
Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med (1970) 5.90
Anatomy of herpes simplex virus DNA VII. alpha-RNA is homologous to noncontiguous sites in both the L and S components of viral DNA. J Virol (1977) 5.31
Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43
Early functions of the genome of herpesvirus. I. Characterization of the RNA synthesized in cycloheximide-treated, infected cells. Virology (1971) 3.73
Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology (1973) 3.43
Stimulation of cellular DNA synthesis by human cytomegalovirus. J Virol (1974) 2.54
Human cytomegalovirus stimulates host cell RNA synthesis. J Virol (1975) 2.41
Immediate early antigens in human cytomegalovirus infected cells. Nature (1977) 2.20
Cytomegalovirus: conversion of nonpermissive cells to a permissive state for virus replication. Science (1973) 2.15
Transcription of the genome of pseudorabies virus (A herpesvirus) is strictly controlled. Virology (1979) 1.76
Stimulation of macromolecular synethesis in guinea pig cells by human CMV. Proc Soc Exp Biol Med (1975) 1.67
Replication of human cytomegalovirus DNA: lack of dependence on cell DNA synthesis. J Virol (1976) 1.61
Induction of pre-early nuclear antigen(s) in HEL cells infected with human cytomegalovirus. Microbiol Immunol (1979) 1.59
Physiological state of human embryonic lung cells affects their response to human cytomegalovirus. J Virol (1977) 1.57
Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin. J Virol (1975) 1.48
Induction of cellular DNA synthesis and increased mitotic activity in syrian hamster embryo cells abortively infected with human cytomegalovirus. J Gen Virol (1976) 1.40
False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen. Int J Cancer (1974) 1.33
Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. II. An ultrastructural study of viral penetration. J Virol (1974) 1.28
Synthesis of proteins in cells infected with herpesvirus. VII. Lack of migration of structural viral proteins to the nucleus of arginine-deprived cells. Virology (1971) 1.00
Growth of cytomegalovirus at supra-optimal temperatures. J Gen Virol (1977) 0.98
Expression of the human cytomegalovirus genome in mouse cells and in human-mouse heterokaryons. Arch Virol (1977) 0.94
Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol Assess (2000) 5.10
Early functions of the genome of herpesvirus. I. Characterization of the RNA synthesized in cycloheximide-treated, infected cells. Virology (1971) 3.73
Characterization of the envelope proteins of pseudorabies virus. J Virol (1984) 3.57
Characterization of defective interfering viral particles present in a population of pseudorabies virions. Virology (1974) 2.66
Synthesis of proteins in cells infected with herpesvirus. V. Viral glycoproteins. Virology (1970) 2.62
Genetic basis of the neurovirulence of pseudorabies virus. J Virol (1984) 2.34
Synthesis of proteins in cells infected with herpesvirus, VI. Characterization of the proteins of the viral membrane. Proc Natl Acad Sci U S A (1970) 2.29
Synthesis of proteins in cells infected with herpesvirus. II. Flow of structural viral proteins from cytoplasm to nucleus. Virology (1969) 2.19
Role of a structural glycoprotein of pseudorabies in virus virulence. J Virol (1987) 2.15
Comparative inactivation of viruses by chlorine. Appl Environ Microbiol (1980) 2.04
Concatemeric forms of intracellular herpesvirus DNA. Virology (1976) 2.04
Size and complexity of human cytomegalovirus DNA. Virology (1978) 2.03
Post-transcriptional control of human cytomegalovirus gene expression. Virology (1983) 2.03
Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Virology (1986) 1.98
Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups. Am J Psychiatry (1995) 1.90
Proteins specified by the short unique region of the genome of pseudorabies virus play a role in the release of virions from certain cells. J Virol (1986) 1.89
Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus. J Virol (1987) 1.80
Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin Chem (1999) 1.77
Transcription of the genome of pseudorabies virus (A herpesvirus) is strictly controlled. Virology (1979) 1.76
The prevalence of high-level exercise in the eating disorders: etiological implications. Compr Psychiatry (1998) 1.67
Views on classification and diagnosis of eating disorders. Can J Psychiatry (1995) 1.66
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Unstable DNA synthesized by polyoma virus-infected cells. Virology (1966) 1.62
Replication of human cytomegalovirus DNA: lack of dependence on cell DNA synthesis. J Virol (1976) 1.61
Physiological state of human embryonic lung cells affects their response to human cytomegalovirus. J Virol (1977) 1.57
Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies. Br J Haematol (1994) 1.53
Role of glycoprotein gIII of pseudorabies virus in virulence. J Virol (1988) 1.53
Synthesis of proteins in cells infected with herpesvirus. 3. Relative amino acid content of various proteins formed after infection. Virology (1970) 1.52
Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community. Am J Psychiatry (2001) 1.50
Early functions of the genome of herpesvirus. 3. Inhibition of the transcription of the viral genome in cells treated with cycloheximide early during the infective process. Virology (1974) 1.49
Should amenorrhoea be necessary for the diagnosis of anorexia nervosa? Evidence from a Canadian community sample. Br J Psychiatry (1996) 1.38
Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry (1988) 1.38
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
Synthesis of proteins in cells infected with herpesvirus. IV. Analysis of the proteins in viral particles isolated from the cytoplasm and the nucleus. Virology (1970) 1.36
Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem (1999) 1.35
Synthesis of proteins in cells infected with herpesvirus. IX. Sulfated proteins. Virology (1973) 1.32
Correlation between stimulation of host cell DNA synthesis by human cytomegalovirus and lack of expression of a subset of early virus genes. Virology (1983) 1.31
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
Synthesis of proteins in cells infected with herpesvirus. X. Proteins excreted by cells infected with herpes simplex virus, types 1 and 2. Virology (1975) 1.29
LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res (1999) 1.27
Electron microscopic studies of the DNA of defective and standard pseudorabies virions. Virology (1975) 1.26
Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol (2000) 1.24
Impalement injuries to the thorax as a result of motor vehicle accidents. Ann Thorac Surg (1987) 1.24
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood (1994) 1.20
Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes (2002) 1.20
Validation of a brief measure of posttraumatic stress disorder: the Distressing Event Questionnaire (DEQ). Psychol Assess (2000) 1.19
Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. Am J Vet Res (1985) 1.17
Site of protein synthesis in cells infected with pseudorabies virus. Virology (1967) 1.17
Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet (2002) 1.17
A comparison of two populations of defective, interfering pseudorabies virus particles. Virology (1976) 1.16
Nature of the block in the expression of some early virus genes in cells abortively infected with human cytomegalovirus. Virology (1983) 1.15
Depression and stages of change for smoking in psychiatric outpatients. Addict Behav (2001) 1.13
Correlation between replication and degradation of cellular DNA in polyoma virus-infected cells. Virology (1967) 1.13
The clinician-investigator interface in psychiatry I--Values and problems. Can J Psychiatry (1989) 1.12
Early functions of the genome of herpesvirus. II. Inhibition of the formation of cell-specific polysomes. Virology (1971) 1.12
Fate of parental herpesvirus DNA. Virology (1976) 1.12
Effect of herpesvirus infection on the synthesis of cell-specific RNA. Virology (1972) 1.12
The clinician-investigator interface in psychiatry: II--The role of the Clinical Investigation Unit. Can J Psychiatry (1989) 1.12
A brief review of the biochemistry of herpesvirus-host cell interaction. Cancer Res (1973) 1.10
Synthesis of proteins in cells infected with herpesvirus. I. Structural viral proteins. Virology (1969) 1.09
Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene (2006) 1.08
Effect of 5-fluorouracil on the multiplication of a virulent virus (pseudorabies) and an oncogenic virus (polyoma). Virology (1967) 1.05
Control of abundance of immediate-early mRNA in herpesvirus (pseudorabies)-infected cells. Virology (1982) 1.03
The role of defective cytomegalovirus particles in the induction of host cell DNA synthesis. Virology (1977) 1.02
Multiple defects in the genome of pseudorabies virus can affect virulence without detectably affecting replication in cell culture. Virology (1987) 1.02
Synthesis of proteins in cells infected with herpesvirus. VII. Lack of migration of structural viral proteins to the nucleus of arginine-deprived cells. Virology (1971) 1.00
Self-report symptoms that predict major depression in patients with prominent physical symptoms. Int J Psychiatry Med (1990) 1.00
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome. Leukemia (2011) 0.99
Mode of antiviral action of 5-iodouracil deoxyriboside. J Mol Biol (1966) 0.99
Follicular carcinoma of the thyroid presenting with hematuria: a case report. Surgery (1986) 0.98
Anorexia nervosa and bulimia nervosa. CMAJ (1989) 0.97
Incorporation of 5-bromodeoxyuridine and 5-iododeoxyuridine into viral DNA and its effect on the infective process. Ann N Y Acad Sci (1965) 0.97
Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis. Virology (1978) 0.96
Feature distribution and background knowledge in category learning. Q J Exp Psychol A (2000) 0.96
Differential incorporation of iododeoxyuridine into the DNA of pseudorabies virus-infected and noninfected cells. Virology (1967) 0.96
Analysis of an origin of DNA replication located at the L terminus of the genome of pseudorabies virus. J Virol (1991) 0.95
Nucleotide sequences at recombinational junctions present in pseudorabies virus variants with an invertible L component. J Virol (1989) 0.95
Platypnea-orthodeoxia as a cause of unexplained hypoxemia in an 82-yr-old female. Cathet Cardiovasc Diagn (1990) 0.95
Replication of herpesvirus DNA. III. Rate of DNA elongation. J Virol (1977) 0.94
Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology (2004) 0.94
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg (2000) 0.94
Development and validation of the sources of trauma-related guilt survey-war-zone version. J Trauma Stress (1997) 0.94
Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood (1994) 0.94
Control of certain aspects of the infective process by progeny viral DNA. Virology (1965) 0.94
Studies on the biogenesis of herpesvirus envelope. Nature (1972) 0.93
A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol (1994) 0.93
Seasonal fluctuations in mood and eating behavior in bulimia nervosa. Int J Eat Disord (1994) 0.93
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis. Cancer Res (1999) 0.92
Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. Cancer Res (1991) 0.92
Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia. Biochem Biophys Res Commun (2000) 0.92
Depression in anorexia nervosa and bulimia nervosa: discriminating depressive symptoms and episodes. J Psychosom Res (1994) 0.90
Excretion of specific glycoproteins by cells infected with herpes simplex virus, types 1 and 2. Prog Med Virol (1975) 0.90
Rate and prediction of relapse in bulimia nervosa. Am J Psychiatry (1994) 0.90